Treatment of prostate cancer in obese patients.
Obesity is a complex, chronic disease that has reached epidemic proportions in the United States. Obesity is now linked with numerous health conditions, including many oncologic diagnoses. Its association with prostate cancer, the most prevalent cancer in men, has also been investigated, with studies suggesting a direct relationship between increasing obesity and prostate cancer mortality. Outcomes data for specific interventions in obese patients with prostate cancer have only recently begun to emerge. Surgery, while feasible even in the very obese, may result in less than optimal cancer control rates. Brachytherapy data are emerging, and are promising. No outcomes data are available for the use of external-beam radiation in obese patients. Long-term data for external-beam radiation, as well as for surgery and brachytherapy, are required to determine the most appropriate treatment for obese patients with prostate cancer. These data, coupled with a more thorough understanding of the biochemical relationship between obesity and prostate cancer, will be necessary to make optimal management decisions for obese patients with prostate cancer in the future.
Mitsuyama
Hiroki
H
Department of Radiation Oncology, University of Washington, Medical Center, USA.
Wallner
Kent E
KE
Merrick
Gregory S
GS
D015992:Body Mass Index; D002986:Clinical Trials as Topic; D006801:Humans; D008297:Male; D009765:Obesity / Q000150:complications*; D011471:Prostatic Neoplasms / Q000150:complications / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D014481:United States / Q000453:epidemiology